Kodjikian Laurent

Gullon Chloé, Elbany Sandra, Romain-Scelle Nicolas, Burillon Carole, Dot Corinne, Mathis Thibaud et al.

FAc-implant effectively improved vision and reduced swelling in recurrent inflammatory macular oedema, with limited side effects, offering a valuable long-term treatment option.

Fricker Jules, Nahon-Esteve Sacha, Tick Sarah, Nhari Maxime, Chotard Géraldine, Nguyen Anh-Minh et al.

FAc implants improved vision and reduced treatment burden in radiation maculopathy, but required careful monitoring for intraocular pressure elevation.

Kodjikian Laurent, Duarte Lilianne, Singh Pankaj, Habib Maged, Gonzalez Victor

A decade of FAc implant use for DMO showed good efficacy and safety, despite IOP/cataract risks, offering a valuable sustained-release treatment option for patients.

Metayer Charline, Kodjikian Laurent, Nguyen Anh-Minh, Loria Olivier, Chaperon Mayeul, Ghesquieres Hervé et al.

This study found aqueous humor IL-10 levels decrease with successful vitreoretinal lymphoma treatment, but persistent or rising levels predict ocular relapse, making IL-10 a useful monitoring biomarker.

Chacun Samuel, Kodjikian Laurent, Ricard Cécile, Elbany Sandra, Marthelot Violaine, Akesbi Jad et al.

Switching dexamethasone implants from "as needed" to proactive dosing improved vision and reduced macular swelling in various conditions, offering better outcomes without increased eye pressure.

Rezkallah Amina, Mathis Thibaud, Abukhashabah Amro, Voirin Nicolas, Malclès Ariane, Agard Émilie et al.

Dexamethasone implants cause ocular hypertension in 32.6% of eyes, often managed topically. Younger age, male sex, uveitis, and pre-existing glaucoma increase risk, but repeat injections don't raise cumulative risk.

Verrecchia Sarah, Chiambaretta Fredéric, Kodjikian Laurent, Nakouri Yasemin, El Chehab Hussam, Mathis Thibaud et al.

Intravitreal injections significantly worsen ocular surface symptoms and quality of life immediately post-procedure, highlighting the need to optimize pre-existing ocular surface health and injection protocols for patient comfort.

Rosenblatt Amir, Udaondo Patricia, Cunha-Vaz José, Sivaprasad Sobha, Bandello Francesco, Lanzetta Paolo et al.

This real-world study found dexamethasone implants effectively improve vision and reduce macular swelling in DME, especially in earlier disease and treatment-naïve eyes, suggesting potential for shorter treatment intervals.

Bilgic Alper, Sudhalkar Aditya, Kodjikian Laurent, Vasavada Viraj, Vasavada Shail, Bhojwani Deepak et al.

Dexamethasone implants effectively improved vision and reduced swelling in treatment-naive DME patients, requiring few injections. However, monitor for elevated eye pressure and cataract development.

Rezkallah Amina, Mathis Thibaud, Denis Philippe, Kodjikian Laurent

XEN gel stents effectively lowered steroid-induced high eye pressure in 5 patients receiving dexamethasone implants, allowing continued sight-saving treatment. This offers a safe solution for steroid responders.

Sudhalkar Aditya, Kodjikian Laurent, Chhablani Jay, Bhojwani Deepak, Vasavada Abhay

Anterior positioning of dexamethasone implants in the eye significantly increases the risk of ocular hypertension, especially early-onset, highlighting the importance of implant placement for glaucoma management.

Pochat-Cotilloux Celine, Bienvenu Jacques, Nguyen Anh-Minh, Ohanessian Robin, Ghesquières Hervé, Sève Pascal et al.

This study found specific IL-10 levels and IL-10/IL-6 ratios in ocular fluids accurately screen for vitreoretinal lymphoma, aiding earlier diagnosis and potentially improving patient outcomes.

Rezkallah Amina, Kodjikian Laurent, Malclès Ariane, Dot Corinne

Malclès Ariane, Dot Corinne, Voirin Nicolas, Vié Anne-Laure, Agard Émilie, Bellocq David et al.

This study found Ozurdex caused temporary ocular hypertension in 28.5% of eyes, manageable with drops. Identifying risk factors like younger age or pre-existing glaucoma helps assess individual patient risk.

Malclès Ariane, Dot Corinne, Voirin Nicolas, Agard Émilie, Vié Anne-Laure, Bellocq David et al.

Real-world data shows Ozurdex effectively improves vision and reduces macular edema in DME patients over three years, offering a valuable long-term treatment option despite potential side effects.

Vié Anne-Laure, Kodjikian Laurent, Malclès Ariane, Agard Emilie, Voirin Nicolas, El Chehab Hussam et al.

Dexamethasone implants caused more frequent and severe IOP elevations in glaucoma/ocular hypertension patients, often requiring additional treatment or surgery. Close IOP monitoring is crucial, especially for these patients.

Garnier Steven, Rahmi Ahmed, Grasswil Cédric, Kodjikian Laurent

This study found 360° retinotomy for severe PVR-RD achieved 70% reattachment, but with poor visual outcomes and complications, suggesting it's a last resort for complex cases.

Kodjikian Laurent, Couprie Jérémy, Hachicha Walid, Timour Quadiri, Devouassoux Mojgan, Builles Nicolas et al.

Vancomycin microparticles effectively prevented experimental endophthalmitis in rabbits, releasing drug for hours with only transient, mild retinal inflammation, suggesting potential for cataract surgery prophylaxis.

Baillif Stéphanie, Ecochard René, Casoli Emmanuelle, Freney Jean, Burillon Carole, Kodjikian Laurent

This study found *S. epidermidis* biofilm formation on IOLs varied significantly by material, with silicone and hydrophobic acrylic showing more binding than hydrophilic acrylic and PMMA. This impacts IOL selection for infection risk.

Garweg Justus G, Moser Frank, Kodjikian Laurent, Halberstadt Markus

This study found that most posterior complications after cataract surgery requiring vitreoretinal intervention were successfully resolved, often with a single surgery, leading to improved vision and anatomical outcomes.

Scherrer Janine, Iliev Milko E, Halberstadt Markus, Kodjikian Laurent, Garweg Justus G

This study found inactive ocular toxoplasmosis causes permanent visual field defects in over 94% of eyes, often more sensitively detected by perimetry than visual acuity, highlighting its clinical utility.

Kodjikian Laurent, Beby Francis, Spire Myriam, Gambrelle Joel, Hubert Isabelle, Burillon Carole et al.

This study found combined phacofragmentation, vitrectomy, and Artisan lens implantation effectively treated traumatic subluxated cataracts, significantly improving vision. It's a promising option, but long-term corneal health requires further evaluation.

Kodjikian Laurent, Gain Philippe, Donate David, Rouberol Frédéric, Burillon Carole

A young woman developed malignant glaucoma after phakic IOL implantation for high myopia. This rare complication, unresponsive to medical therapy, required surgery, highlighting a potential risk of these lenses.